CP101 for the Treatment of Ulcerative Colitis
Latest Information Update: 11 Dec 2024
At a glance
- Drugs CP 101 Finch Therapeutics Group (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 09 Dec 2024 Status changed from recruiting to active, no longer recruiting.
- 27 Nov 2023 Status changed from not yet recruiting to recruiting.
- 05 Sep 2023 Planned End Date changed from 30 Jun 2025 to 2 Jun 2025.